두경부암에서 Protein Kinase의 역할

참고문헌 (43)

1. "The origins of protein phosphorylation", 4, pp.~30 (2002)
2. "Conversion of phosphorylase b to phosphorylasea in muscle extracts", 216, pp.121~32 (1955)
3. "Transforming gene product of Rous sarcomavirus phosphorylates tyrosine", 77, pp.1311~5 (1980)
4. "Anticancer therapy targeting the erbB familyof receptor tyrosine kinases. Semin Oncol 2001;28 (5 suppl 16 )67-79.", pp.5 67~16 79 (2001)
5. "Epidermal growth factor receptortyrosine kinase as a target for anticancer therapy", pp.60 15~1 23 2 (2000)
6. "The epidermalgrowth factor receptor family as a central element for cellular signaltransduction and diversification", 8, pp.11~31 (2001)
7. "Epidermal growth factorreceptors:Critical mediators of multiple receptor pathways", 11, pp.184~9 (1999), CurrOpin Cell Biol
8. "EGF receptor", 31, pp.637~43 (1999)
9. "Targeting epidermal growth factor receptor inlung cancer", 4, pp.317~24 (2002)
10. "Cell signaling by receptor tyrosine kinases", 103, pp.211~25 (2000)
11. "Oncogenes and angiogenesis:Signaling three-dimensional tumor growth", 5, pp.24~33 (2000)
12. "774 in patients with advanced solid tumors", pp.~358
13. "A phase II trial of theepidermal growth factor receptor", pp.~774 (2001), EGFR-expressing
14. "is well tolerated and active in patients with solid Results of a phase I trial", pp.2240~50 (2002)
15. "Selective oral epidermal growth factor receptortyrosine kinase inhibitor ZD1839 is generally well-tolerated and hasactivity in non-small-cell lung cancer and other solid tumors:Resultsof a phase I trial", 20, pp.3815~25 (2002)
16. "A minute chromosome in human chronicgranulocytic leukemia", 132, pp.1497~ (1960)
17. "Letter:A new consistent chromosomal abnormality inchronic myelogenous leukemia identified by quinacrine fluorescenceand Giemsa staining", 243, pp.290~3 (1973)
18. "as initial therapy for patientswith newly diagnosed Ph+ chronic myeloid leukemia Result of a randomized phase III study vs interferon-alpha + cytarabin" (2002)
19. "targeted anticancer drug.Nat Rev Drug Discov", pp.493~502 (2002)
20. "Philadelphia chromosome-positive leukemias:From basic mechanisms to moleculartherapeutics", 138, pp.819~30 (2003)
21. "A new acute transforming feline retrovirus and relationship ofits oncogene v-kit with the protein kinase gene family", 320, pp.415~21 (1986)
22. "Coexpression of the stem cell factor and the c-kit genes in small-celllung cancer", 6, pp.2291~6 (1991)
23. "Evidence for the functional kit receptor in melanoma", o(dera k), pp.176~82 (1997)
24. "Activating c-kitgene mutations in human germ cell tumors", 154, pp.1643~7 (1999)
25. "Gain-of-function mutations of c-kit in human gastrointestinalstromal tumors", 279, pp.577~80 (1998)
26. "Expression of stemcell factor and its receptors by human neuroblastoma cells and tumors", 86, pp.3132~8 (1995)
27. "Usefulness ofplatelet-derived growth factor as a prognostic factor in pulmonaryadenocarcinoma", 58, pp.40~3 (1995)
28. "Expression in lung carcinomas ofplatelet-derived growth factor and its receptors", 77, pp.431~6 (1997)
29. "Inhibition of platelet-derived growth factors reduces interstitialhypertension and increase transcapillary transport in tumors", 61, pp.2929~34 (2001)
30. "resulting in drug resistance", pp.795~806 (2001)
31. "Gleevec-mediated inhibition of Rad51 expression andenhancement of tumor cell radiosensitivity", 63, pp.7377~83 (2003)
32. "Expressionof protein kinases in head and neck squamous cell carcinomas", 124, pp.71~6 (2005)
33. "Synergisticeffects of imatinib in combination with chemotherapeuticdrugs in head and neck cancer", pp.719~571 26 (2005)
34. "Oncogenic kinase signalling", 411, pp.355~65 (2001)
35. "The phosphatidylinositol 3-kinase-AKT pathwayin human cancer", 2, pp.489~501 (2002)
36. "Changes in the balance of phosphoinositide 3-kinase", protein kinase B determine a phenotype of visceral and vascular smooth muscle cells, 1999, 727~40
37. "The protein kinase encoded by the Akt proto-oncogene is a targetof the PDGF-activated phosphatidylinositol 3-kinase", 81, pp.727~36 (1995)
38. "Cell-autonomousregulation of cell and organ growth in Drosophilia by Akt", PKB, 1999, pp.1, 500~6
39. "Cancer:Survival pathways meet their end", 428, pp.267~9 (2004)
40. "Survival signaling by Akt and eIF4E in oncogenesis and cancertherapy", 428, pp.332~7 (2004)
41. "Antitumoractivity of UCN-01 a selective inhibitor of protein kinase C", pp.4888~92
42. "Persitent activation of the Akt pathway in head and necksquamous cell carcinoma:A potent target for UCN-01", 10, pp.4029~37 (2004), Clin CancerRes
43. "Activation of tyrosine kinases in cancer", 8, pp.531~8 (2003)

관련 논문AI추천